How Does Dialysis Care Differ for Minority Patients? How Does Dialysis Care Differ for Minority Patients?
A large study found that patients from racial minority groups were less likely to receive certain types of dialysis or to receive kidney transplants. Medscape Nephrology (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - February 2, 2016 Category: Urology & Nephrology Tags: Nephrology Commentary Source Type: news
Kidney Stones on the Rise in the United StatesKidney Stones on the Rise in the United States
Adolescents, females, and blacks saw the greatest increases in the incidence of nephrolithiasis during a 16-year period. Medscape Medical News (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - January 28, 2016 Category: Urology & Nephrology Tags: Nephrology News Source Type: news
Treatment of HCV in Patients With Advanced Renal DiseaseTreatment of HCV in Patients With Advanced Renal Disease
A new drug combination may provide safe treatment of hepatitis C for patients with end-stage renal disease. Medscape Nephrology (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - January 22, 2016 Category: Urology & Nephrology Tags: Nephrology Viewpoint Source Type: news
Outcomes Worse in Dialysis Started Without Nephrologist CareOutcomes Worse in Dialysis Started Without Nephrologist Care
'Whatever it takes,' says Dr Jeffrey Berns, we need to get patients with advanced kidney disease into the care of a nephrologist before dialysis is initiated to reduce mortality during the first year. Medscape Nephrology (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - January 11, 2016 Category: Urology & Nephrology Tags: Nephrology Commentary Source Type: news
Cocoa Flavanols Linked to Vascular Protection in ESRDCocoa Flavanols Linked to Vascular Protection in ESRD
In patients with end-stage renal disease, ingestion of cocoa flavanols was associated with improved vascular functions and improved cardiac health, new research suggests. Medscape Medical News (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - January 7, 2016 Category: Urology & Nephrology Tags: Nephrology News Source Type: news
Call to Reduce Sugar in Drinks, Cutting Obesity, Diabetes RatesCall to Reduce Sugar in Drinks, Cutting Obesity, Diabetes Rates
A UK modeling study demonstrates significant reductions in overweight, obesity, and type 2 diabetes that could result if beverage manufacturers gradually reduced added sugar over 5 years. Medscape Medical News (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - January 7, 2016 Category: Urology & Nephrology Tags: Diabetes & Endocrinology News Source Type: news
The Medical Wisdom of Yogi BerraThe Medical Wisdom of Yogi Berra
Yogi Berra's tangled aphorisms may offer a wealth of wisdom to today's physicians, says Dr Seifter. Medscape Nephrology (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - January 5, 2016 Category: Urology & Nephrology Tags: Nephrology Expert Column Source Type: news
Which Kidney Cancer Drug on Progression? Surprising AnswersWhich Kidney Cancer Drug on Progression? Surprising Answers
Although cabozantinib has shown the best progression-free survival ever seen, nivolumab improves overall survival and has fewer adverse events. Medscape Medical News (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - January 5, 2016 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
More Kidney Disease With Long-Term Statins Seen in Cohort StudyMore Kidney Disease With Long-Term Statins Seen in Cohort Study
"Clinicians should tell their patients that there may be statin side effects we are not aware of, but there are also benefits that we are aware of," say researchers; cause-and-effect were not shown in their study. Heartwire from Medscape (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - December 22, 2015 Category: Urology & Nephrology Tags: Cardiology News Source Type: news
Proton Pump Inhibitors and Hypomagnesemia in General PopulationProton Pump Inhibitors and Hypomagnesemia in General Population
What's the impact of prolonged PPI use on magnesium levels? American Journal of Kidney Diseases (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - December 14, 2015 Category: Urology & Nephrology Tags: Nephrology Journal Article Source Type: news
Infertility in Men Tied to Heart Disease, Chronic Conditions Infertility in Men Tied to Heart Disease, Chronic Conditions
Compared with men with vasectomies or receiving fertility tests, those with infertility had increased risks for heart disease, diabetes, substance abuse, liver disease, and renal disease. Medscape Medical News (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - December 7, 2015 Category: Urology & Nephrology Tags: Family Medicine/Primary Care News Source Type: news
Acute Kidney Injury Linked to BRAF Inhibitors in MelanomaAcute Kidney Injury Linked to BRAF Inhibitors in Melanoma
Treatment with vemurafenib and dabrafenib was associated with acute renal toxicity in patients with melanoma, according to data from the FDA Adverse Event Reporting System. Medscape Medical News (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - November 17, 2015 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
Big Trials Disappoint at Kidney WeekBig Trials Disappoint at Kidney Week
The mystifying relation between vascular complications and kidney disorders has investigators stumped after negative results from three highly anticipated trials of statins, steroids, and fish oils. Medscape Medical News (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - November 11, 2015 Category: Urology & Nephrology Tags: Nephrology News Source Type: news
Managing AKI Just Got More StressfulManaging AKI Just Got More Stressful
Do the risks of the furosemide stress test outweigh the value for patients with acute kidney injury? Medscape Nephrology (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - October 29, 2015 Category: Urology & Nephrology Tags: Nephrology Viewpoint Source Type: news
John H. Laragh: The Legacy of an Iconic Clinician-ScientistJohn H. Laragh: The Legacy of an Iconic Clinician-Scientist
John Laragh pioneered research in aldosterone and MR antagonism in CV disease and CKD, revolutionizing treatment of these disorders as well as that for hypertension and diabetes. Medscape Nephrology (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - October 29, 2015 Category: Urology & Nephrology Tags: Nephrology Expert Column Source Type: news
